Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
benzbromarone (1 trial)
bi 853520 (1 trial)
d-0120 (6 trials)
d-0316 (2 trials)
d-1553 (6 trials)
in10018 (1 trial)
allopurinol (zyloprim) (1 trial)
d-0502 (4 trials)
palbociclib (ibrance) (1 trial)
Breast Neoplasms (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Hyperuricemia (Phase 2)
Lung Neoplasms (Phase 1)
Neoplasms (Phase 2)
Trials (18 total)
Trial APIs (9 total)